Inovio secures FDA nod for phase 2 segment of Covid-19 DNA vaccine candidate trial

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 17, 2020 at 11:42 PM.

  1. #1 cafead, Nov 17, 2020 at 11:42 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Inovio has secured approval from the US Food & Drug Administration (FDA) to begin phase 2 segment of its planned phase 2/3 clinical trial for its Covid-19 DNA vaccine candidate.

    article source
     
    Quote

Reply to Thread